Maplight Therapeutics Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$17.80

+0.82 (+4.83%)

As of Mar 25, 2:25 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +255.0% upside

Low Target $44.21

Average Target $63.19

High Target $83.67

Current Price $17.80

Current
$17.80

Target
$63.19

$44.21 $63.19 avg $83.67

Scenario Analysis

Bear Case

$44.21

148.4%

Low target

Base Case

$63.19

+255.0%

Avg target

Bull Case

$83.67

+370.1%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$21.55

-17.4% from high

52-Week Low

$12.24

+45.4% from low

Target vs 52W High

$63.19

+193.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%